RELIEF THERAPEUTICS HOLDING ORD SHS Profit Margin

RELIEF THERAPEUTICS HOLDING ORD SHS (RLFTF) currently reports a profit margin of -753.6% as of June 2026. That compares with -874.49% in the prior-year period — up 13.8% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore RELIEF THERAPEUTICS HOLDING ORD SHS's profit margin history and peer comparisons.

RELIEF THERAPEUTICS HOLDING ORD SHS's profit margin increased from -874.49% to -753.6% — a 13.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RELIEF THERAPEUTICS HOLDING ORD SHS's profit margin of -753.6% is lower than the Healthcare sector average of 21.34%. That is roughly 3632.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but RELIEF THERAPEUTICS HOLDING ORD SHS's current -753.6% should be judged against Healthcare norms (sector average: 21.34%) and against RLFTF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -753.6%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for RELIEF THERAPEUTICS HOLDING ORD SHS, and consider following RLFTF for alerts when major investors trade the stock.